Monday, April 28, 1997
A federal prosecutor has
charged David Blech, a leading biotech financier in the early 1990s, with a
single criminal count of securities fraud.
information," which is the equivalent of an indictment but does not
require the consent of a grand jury, was filed last week in the U.S. District
Court for the Southern District of New York.